Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kerala AyurvedaBOM:530163 -0.48%47 PB Ratio is 18.23 as of Aug. 07, 2026, which is 4% above its 10-year median of 17.58. GuruFocus rates BOM:530163 with a GF Score™ of 47/100 and a GF Value™ of ₹320.80 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 921 Drug Manufacturers companies, Kerala Ayurveda ranks worse than 96.2% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-08-07), Kerala Ayurveda's share price is ₹156.00. Kerala Ayurveda's Book Value per Share for the quarter that ended in Mar. 2026 was ₹8.56. Hence, Kerala Ayurveda's PB Ratio of today is 18.23.
Good Sign:
Kerala Ayurveda Ltd stock PB Ratio (=18.11) is close to 1-year low of 18.11.
The historical rank and industry rank for Kerala Ayurveda's PB Ratio or its related term are showing as below:
BOM:530163'
s PB Ratio Range Over the Past 10 Years
Min: 4.97 Med: 17.58 Max: 102.73
Current: 18.44
During the past 13 years, Kerala Ayurveda's highest PB Ratio was 102.73. The lowest was 4.97. And the median was 17.58.
BOM:530163's PB Ratio is ranked worse than 96.2% of 921
companies
in the Drug Manufacturers industry
Industry Median: 1.96
vs BOM:530163: 18.44
During the past 12 months, Kerala Ayurveda's average Book Value Per Share Growth Rate was 8.50% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Kerala Ayurveda was 68.80% per year. The lowest was -24.50% per year. And the median was 4.40% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Kerala Ayurveda PB Ratio Related Terms
Kerala Ayurveda PB Ratio Historical Data
* Premium members only.
The historical data trend for Kerala Ayurveda's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Kerala Ayurveda's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kerala Ayurveda PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Kerala Ayurveda's PB Ratio distribution charts can be found below:
* The bar in red indicates where Kerala Ayurveda's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Kerala Ayurveda's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Kerala Ayurveda (BOM:530163) has a PB Ratio of 18.23 as of Aug. 07, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Kerala Ayurveda and its competitors. This is near median its historical median of 17.58. Over the past decade, Kerala Ayurveda's PB Ratio has ranged from 4.97 to 102.73. According to the industry distribution chart, Kerala Ayurveda ranks #886 out of 921 companies in the Drug Manufacturers industry, placing it in the top 96.2%.
Is Kerala Ayurveda's PB Ratio too high?
Kerala Ayurveda's current PB Ratio of 18.23 is near median its 10-year median of 17.58. Over the past 10 years, this metric has ranged from a low of 4.97 to a high of 102.73. The Drug Manufacturers industry median PB Ratio is 1.96. Kerala Ayurveda's value of 18.23 is 830.1% above this industry median. Based on the distribution chart, Kerala Ayurveda ranks #886 out of 921 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Kerala Ayurveda has a GF Score™ of 47/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Kerala Ayurveda's PB Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Kerala Ayurveda ranks #886 out of 921 companies for PB Ratio. This places Kerala Ayurveda in the lower half of its industry. The industry median PB Ratio is 1.96. Kerala Ayurveda's value of 18.23 is 830.1% above this benchmark. Historically, Kerala Ayurveda's own PB Ratio has ranged from 4.97 to 102.73 over the past decade. While the company's 10-year median is 17.58 vs. the industry median of 1.96, Kerala Ayurveda has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.96, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kerala Ayurveda's current PB Ratio of 18.23 is 830.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Kerala Ayurveda and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kerala Ayurveda's current PB Ratio is 18.23, which is near median its own 10-year median of 17.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kerala Ayurveda stock overvalued right now?
Based on GuruFocus' analysis, Kerala Ayurveda (BOM:530163) is currently considered Possible Value Trap. The stock's GF Value™ is ₹320.80, compared to a current price of ₹156.00 — trading 51.4% below its estimated fair value. The current PB Ratio is 18.23, which is near median its 10-year median of 17.58 and 830.1% above the Drug Manufacturers industry median of 1.96. Kerala Ayurveda's overall GF Score™ is 47/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Kerala Ayurveda (BOM:530163), the current PB Ratio is 18.23 as of Aug. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kerala Ayurveda (BOM:530163) Overvalued in 2026?
Based on GuruFocus' analysis, Kerala Ayurveda stock appears to be undervalued.
The current stock price of ₹156.00 is trading 51.4% below its estimated GF Value™ of ₹320.80.
GuruFocus considers Kerala Ayurveda to be Possible Value Trap.
Key valuation signals for BOM:530163:
PB Ratio: 18.23 (near median its 10-year median of 17.58)
GF Value™: ₹320.80 vs. price of ₹156.00 (51.4% below fair value)
Industry Position: 830.1% above the Drug Manufacturers median (#886 of 921)
No single metric tells the full story. See the BOM:530163 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kerala Ayurveda Ltd is engaged in producing and selling ayurvedic products and providing healthcare services. The company offers ayurvedic medicine products for diabetes and heart health, skin and hair care, kids' health, women's care, men's care, gastro care, respiratory and allergy, general healthcare, massage oils, renal care, and joint care. It provides services through wellness clinics, resorts, hospitals, and academies. The company has only one reportable business segment, i.e., Full-spectrum Ayurvedic wellness. It generates maximum revenue from the sale of products. Geographically, the company generates maximum revenue from its business in India and also has some exposure to other markets.
47GF Score
Get the complete analysis for BOM:530163
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:530163 has been successfully added to your 
